Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment.

Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment.

<h4>Objective</h4>To investigate whether changes in the plasma level of soluble urokinase plasminogen activator receptor (suPAR) can be used to monitor tuberculosis (TB) treatment efficacy.<h4>Design</h4>This prospective cohort study included 278 patients diagnosed with activ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paulo Rabna, Andreas Andersen, Christian Wejse, Ines Oliveira, Victor Francisco Gomes, Maya Bonde Haaland, Peter Aaby, Jesper Eugen-Olsen
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/1b94c15df9c04928978ae2d95e2390e8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares